CT7439 an oral first-in class selective CDK12 and 13 inhibitor and cyclin K degrader: Profiling activity and combination efficacy in an ovarian cancer model

Zejula (niraparib) - GSK, J&J

saracatinib (AZD0530) - AstraZeneca

carboplatin - Generic mfg.

Lynparza (olaparib) - Merck (MSD), AstraZeneca

CT7439 - Carrick Therap

Ashwani K. Bahl; Matthew Carr; Stuart Thompson; Adrian Campbell; Andrew Leishman; Edward Ainscow

Mar 26, 2025